Acta Scientific Clinical Case Reports

Case ReportVolume 3 Issue 8

Struma Ovarii: A Rare Case Report

Somya Sharma1, Anand Lodhi2 and Virendra Bhandari3*

1Junior Resident, Department of Radiation Oncology, Sri Aurobindo Medical College and PG Institute, Indore, India
2Resident, Department of Radiation Oncology, Sri Aurobindo Medical College and PG Institute, Indore, India
3Professor, Department of Radiation Oncology, Sri Aurobindo Medical College and PG Institute, Indore, India

*Corresponding Author: Virendra Bhandari, Professor, Department of Radiation Oncology, Sri Aurobindo Medical College and PG Institute, Indore, India

Received: June 28, 2022; Published: July 18, 2022

Abstract

Struma ovarii is an extremely rare teratoma of ovary representing 0.5-1% of all ovarian tumour and 2-5% all dermoid tumors of ovary. It occur mostly in adults usually between 30 and 50 years of age before menopause. It is most common type of monodermal teratoma and classified as teratoma only if composed predominantly of 50% of thyroid tissue.. We present a case of 52year postmenopausal woman who presented with pain in abdomen associated with abdominal distension. Imaging showed large solid cystic mass lesion in left adenexa and fallopian tube and raised carcinoma antigen (CA)-125 which was suspicious for Carcinoma Ovary. She underwent surgery, Post operative report confirmed the diagnosis of struma ovarii/strumal carcinoid of left ovary. We representing this case because of presence of thyroid tissue comprising more than 50% of overall mass.

Keywords: Ovarian Tumour; Struma Ovarii; Ascites

Bibliography

  1. Wee JY., et al. “Struma ovarii: management and follow-up of a rare ovarian tumour”. Singapore Medical Journal 1 (2015): 35.
  2. Pari P., et al. “Struma Ovarii: An Unusual Case Report”. Journal of Gynecologic Surgery5 (2020): 296-298.
  3. Mustafa A., et al. “Case Report of a Struma Ovarii”. American Journal of Medical Case Reports8 (2016): 272-274.
  4. Yoo SC., et al. “Clinical characteristics of struma ovarii”. Journal of Gynecologic Oncology2 (2008): 135-138.
  5. Leung YC and Hammond IG. “Limitations of CA125 in the preoperative evaluation of a pelvic mass: struma ovarii and ascites”. Australian and New Zealand Journal of Obstetrics and Gynaecology2 (1993): 216-217.
  6. O'connell ME., et al. “Malignant struma ovarii: presentation and management”. The British Journal of Radiology 749 (1990): 360-363.
  7. Makani S., et al. “Struma Ovarii with a focus of papillary thyroid cancer: a case report and review of the literature”. Gynecologic oncology3 (2004): 835-839.
  8. Rockson O., et al. “Struma ovarii: two case reports of a rare teratoma of the ovary”. Journal of Surgical Case Reports12 (2020): rjaa493.
  9. Kunstmann L and Fénichel P. “Struma ovarii, a rare form of ovarian tumor”. Gynecologie, Obstetrique and Fertilite1 (2007): 49-54.

Citation: Virendra Bhandari., et al. “Struma Ovarii: A Rare Case Report". Acta Scientific Clinical Case Reports 3.8 (2022): 27-29.

Copyright: © 2022 Virendra Bhandari., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.



News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is November 30, 2022.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US